Lion Point Capital as of Dec. 31, 2025
Portfolio Holdings for Lion Point Capital
Lion Point Capital holds 39 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals (MIST) | 7.9 | $1.5M | 755k | 2.02 | |
| Praxis Precision Medicines I Com New (PRAX) | 6.8 | $1.3M | 4.5k | 294.74 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 4.6 | $890k | 68k | 13.18 | |
| Fennec Pharmaceuticals (FENC) | 4.5 | $866k | 112k | 7.70 | |
| Jasper Therapeutics Com New (JSPR) | 4.4 | $851k | 465k | 1.83 | |
| Benitec Biopharma Com New (BNTC) | 4.3 | $835k | 62k | 13.47 | |
| Royalty Pharma Shs Class A (RPRX) | 4.3 | $827k | 21k | 38.64 | |
| Geron Corporation (GERN) | 3.9 | $763k | 578k | 1.32 | |
| Syndax Pharmaceuticals (SNDX) | 3.9 | $756k | 36k | 21.01 | |
| Ardelyx (ARDX) | 3.9 | $750k | 129k | 5.83 | |
| Cue Biopharma (CUE) | 3.5 | $673k | 2.2M | 0.31 | |
| Disc Medicine (IRON) | 3.3 | $643k | 8.1k | 79.41 | |
| Sarepta Therapeutics (SRPT) | 3.2 | $613k | 29k | 21.52 | |
| Biohaven (BHVN) | 3.0 | $584k | 52k | 11.29 | |
| Humacyte (HUMA) | 2.5 | $480k | 500k | 0.96 | |
| Kura Oncology (KURA) | 2.5 | $478k | 46k | 10.39 | |
| Seres Therapeutics Com New (MCRB) | 2.4 | $470k | 32k | 14.88 | |
| Compass Pathways Sponsored Ads (CMPS) | 2.1 | $400k | 58k | 6.90 | |
| Day One Biopharmaceuticals I (DAWN) | 2.0 | $391k | 42k | 9.32 | |
| Regenxbio Inc equity us cm (RGNX) | 2.0 | $383k | 27k | 14.40 | |
| Bridgebio Pharma (BBIO) | 2.0 | $383k | 5.0k | 76.49 | |
| Mineralys Therapeutics (MLYS) | 2.0 | $381k | 11k | 36.29 | |
| Ventyx Biosciences (VTYX) | 1.9 | $375k | 42k | 9.03 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.9 | $366k | 5.5k | 66.55 | |
| Dyne Therapeutics (DYN) | 1.8 | $352k | 18k | 19.56 | |
| Uniqure Nv SHS (QURE) | 1.8 | $352k | 15k | 23.93 | |
| Pacira Pharmaceuticals (PCRX) | 1.8 | $349k | 14k | 25.88 | |
| Viatris (VTRS) | 1.8 | $345k | 28k | 12.45 | |
| Brooks Automation (AZTA) | 1.7 | $323k | 9.7k | 33.26 | |
| Rocket Pharmaceuticals (RCKT) | 1.6 | $302k | 86k | 3.51 | |
| Janux Therapeutics (JANX) | 1.4 | $262k | 19k | 13.80 | |
| Edgewise Therapeutics (EWTX) | 1.2 | $226k | 9.1k | 24.82 | |
| Innoviva (INVA) | 0.8 | $164k | 8.2k | 19.99 | |
| Arcutis Biotherapeutics (ARQT) | 0.8 | $153k | 5.3k | 29.04 | |
| Innate Pharma S A Sponsored Ads (IPHA) | 0.7 | $142k | 81k | 1.75 | |
| Minerva Neurosciences Com New (NERV) | 0.7 | $141k | 35k | 4.02 | |
| Gh Research Ordinary Shares (GHRS) | 0.7 | $130k | 10k | 12.70 | |
| Spruce Biosciences Com New (SPRB) | 0.5 | $87k | 1.0k | 87.11 | |
| Mersana Therapeutics (MRSN) | 0.0 | $2.9k | 100.00 | 28.93 |
